Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor ...

The impact of popular U.S. weight-loss drugs like Ozempic and Wegovy (GLP-1 receptor agonists), upon their initial ...

A meta-analysis of 10,362 patients with inflammatory bowel disease has found that GLP-1 receptor agonists are safe and ...

Danish pharmaceutical manufacturer Novo Nordisk on Dec. 22 announced that the U.S. Food and Drug Administration (FDA) has ...

Indian pharma major Lupin Limited announced that it has entered into an exclusive license, supply and distribution agreement ...

A recent study found that Glucagon-like peptide-1 (GLP-1) receptor agonist use in hypertrophic cardiomyopathy (HCM) patients ...

Lupin signed an exclusive licensing, supply and distribution pact with China's Gan & Lee for Bofanglutide, a fortnightly ...

Expanded use of GLP-1 drugs may lead to more side effects, already the subject of thousands of lawsuits now moving through ...

Odds of vertebral compression fractures or surgical intervention were significantly lower among GLP-1 RA users ...

Treatment with GLP-1RAs led to a reduction in both body weight (pooled mean difference, -9.7kg) and WOMAC pain score (pooled mean difference, -0.49 points). Treatment with glucagon-like peptide-1 ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

Lupin announced that it has entered into an exclusive license, supply, and distribution agreement with China-based Gan & Lee Pharmaceuticals for Bofanglutide, a novel fortnightly GLP-1 receptor ...